Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Echocardiographic Evaluation of Nebivolol in Hypertension
NCT01206439Phase 4Terminated
- Start
- Sep 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nebivolol in hypertension (HTN). Primary endpoint: Change in Systolic and Diastolic Myocardial Function at 180 days. Started Sep 2010; status: terminated.
02
Drugs
nebivolol
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01206439.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01206439.